Suction Cervical Stabilizer Compared to Standard Tenaculum for Intrauterine Procedures

Description

To evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between intrauterine procedures employing a suction cervical stabilizer (new device, FDA approved, atraumatic) or single-tooth tenaculum (standard, traumatic). This device, cleared by the FDA in 2023, was studied in Europe and showed pain reduced by up to 73% and bleeding reduced by 78% compared to the single-tooth tenaculum for intrauterine contraceptive device insertion. The investigators seek to study this device in the United States, and trial it among all intrauterine procedures.

Conditions

Intrauterine Device (IUD), Abnormal Uterine Bleeding

Study Overview

Study Details

Study overview

To evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between intrauterine procedures employing a suction cervical stabilizer (new device, FDA approved, atraumatic) or single-tooth tenaculum (standard, traumatic). This device, cleared by the FDA in 2023, was studied in Europe and showed pain reduced by up to 73% and bleeding reduced by 78% compared to the single-tooth tenaculum for intrauterine contraceptive device insertion. The investigators seek to study this device in the United States, and trial it among all intrauterine procedures.

Safety and Efficacy of a Suction Cervical Stabilizer Compared to the Standard Tenaculum for Intrauterine Procedures in the Clinic Setting

Suction Cervical Stabilizer Compared to Standard Tenaculum for Intrauterine Procedures

Condition
Intrauterine Device (IUD)
Intervention / Treatment

-

Contacts and Locations

Indianapolis

Indiana University Hospital, Indianapolis, Indiana, United States, 46202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * • Age 18 years or older
  • * Speaks and reads in English
  • * Able to consent on their own
  • * Will undergo any intrauterine procedure using the Carevix (for exposure group) or using Tenaculum (for Control Group)
  • * Cervix at least 26 mm in diameter
  • * Twenty providers performing this procedure
  • * • Vaginal bleeding of unknown origin
  • * Cervix less than 26 mm in diameter
  • * Nabothian cyst on anterior lip of cervix
  • * Cervical myomas
  • * Cervical abnormalities
  • * Pregnant

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Indiana University,

Alissa Conklin, MD, PRINCIPAL_INVESTIGATOR, Indiana University School of Medicine

Study Record Dates

2024-12-30